The Type 214 is a smaller submarine, but capable nonetheless. According to the manufacturer’s website, the Type 214 submarine can undertake a number of different missions. These range from “littoral ...
Nektar’s principal asset NKTR-214, a pegylated version of IL-2, previously failed in a monotherapy trial (0% ORR), and we believe it will fail in combination with nivolumab as well. Past studies show ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results